State Board Of Administration Of Florida Retirement System Ngm Biopharmaceuticals Inc Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$1.17 - $1.92 $5,066 - $8,313	4,330 Added 38.24%	15,654 $24,000
Q4 2023 Feb 09, 2024	BUY	$0.6 - $1.31 $6,794 - $14,834	11,324 New	11,324 $9,000
Q2 2022 Aug 05, 2022	BUY	$10.58 - $17.5 $165,619 - $273,945	15,654 New	15,654 $201,000
Q1 2022 May 06, 2022	SELL	$13.81 - $18.6 $170,083 - $229,077	-12,316 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$17.26 - $22.02 $80,397 - $102,569	-4,658 Reduced 27.44%	12,316 $218,000
Q3 2021 Nov 08, 2021	BUY	$20.15 - $26.19 $342,026 - $444,549	16,974 New	16,974 $357,000

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account